This Is a Good Time to Make a Stock-Picking List
As biotech is getting hit and we’re seeing ETF-driven selling, I smell opportunity for sharp traders.
Stocks Are Disconnecting From the Bond Pressure
Bonds slid again, but stocks posted solid gains as buyers hunted for some of the worst performers.
Small Biotech Name Hits Radar With Promising Hair Loss Play
As higher interest rates drive two-tiered market action, I’m watching this name.
Breakout Buyers Caught in Classic Bull Trap
The problem with traps is that they don’t seem like traps until it’s too late.
Indices Churn On Mix of Good and Bad Action
Financials broke down on the flat yield curve while biotech caught the speculative bid.
Amid a Lack of Market Leadership, I’m Eyeing These 2 Stocks
I’m adding to this oil play and biopharma stock as market sees some strange and broad-but-shallow action Tuesday.
Magnificent Seven Hits All-Time High but it’s Not What it Seems
It was an upbeat day driven by poor positioning and too much negativity.
One of My Top Small-Cap Biotech Picks Made a Move. Here’s How I Trade It
The FDA just granted this biopharma name a key designation. Let me show you in detail how I handle a stock like this.
Jobs Update Pushes Odds of a Rate Hike While Trump Calls for Cut
The chances of one or more rate hikes before the end of the year are around 87%.
I’m Stalking Amazon
The market is under pressure but buying opportunities are slowly developing; here’s how I’m trying to time an entry.